Erysipelothrix rhusiopathiae is a small gram-positive rod that causes erysipelas in swine and turkeys. Erysipelas can occur as an acute septicemic or chronic disease, with development of arthritic lesions and endocarditis (31) . Less frequently, it causes polyarthritis in lambs and calves (26) , septicemia in ducks (18) , and occasionally a variety of infections, including skin lesions and endocarditis, in humans (1, 3, 7, 16, 19) . Much of the interest in E. rhusiopathiae has been due to the chronic and progressive character of the arthritic lesions in pigs, which superficially resemble those of human rheumatoid arthritis.
Peptidoglycan antigens form the basis for the classification of this organism into serotypes and subtypes, and at least 22 different serotypes have been identified (11, 17, 22, 32, 33) . Most of the isolates from diseased animals belong to serotype 1 or 2 (32) . Protection is not serotype specific, and varying degrees of cross-protection among different serotypes have been observed (23) . Although protective antisera for passive immunization have been available for many years, the identity of the protective antigen(s) has not been clearly established. White and Verwey (28, 29) described a large-molecular-weight protective antigen in culture supernatants; more recently, Lachmann and Deicher (12) have described smaller-molecular-weight antigenic components by immunoblotting.
Currently available live attenuated or bacterin vaccines do not prevent the chronic form of swine erysipelas, and it has been suggested that vaccination may actually cause an increase in arthritic lesions by hypersensitizing the animal to subsequent contact with the organism (4, 31) . These observations are consistent with the findings of White et al. (27) , who produced synovitis in rabbits by injecting cell extracts of E. rhusiopathiae. (34) were used for growing and screening Xgtll and Xgtll recombinant clones. E. coli BHB2688 and BHB2690, used for preparation of packaging mixes, have been described by Hohn (9) . E. rhusiopathiae strains were grown on brain heart infusion broth supplemented with 10% horse serum. E. coli strains were grown on L agar or L broth (14) . When appropriate, ampicillin was added to media at a concentration of 100 ,ug/ml.
Antigen preparation. Surface antigens of E. rhusiopathiae were obtained by extraction with Triton X-100 as described by Lachmann and Deicher (12) . Briefly, E. rhusiopathiae strains were grown on 10 ml of brain heart infusion broth supplemented with 10% horse serum. Cells were washed twice with 20 mM Tris (pH 7.6) and resuspended in 0.5 ml of 20 mM Tris (pH 7.6) containing 0.5% Triton X-100 (Sigma Co., St. Louis, Mo.). Cells were incubated at 37°C for 1 h under rotation. Samples were finally centrifuged at 9,000 x g for 5 min, and cells and supernatants were separately stored at -75°C until further analysis. Total cell lysates from E. rhusiopathiae were prepared by boiling the cells for 5 min in Laemmli loading buffer (13) . Cell debris was separated by centrifugation at 10,000 x g for 5 min. Lysates from E. coli lysogens were prepared as follows. Lysogens were grown at 30°C to an optical density at 600 nm of 0.4 to 0.6 and then incubated at 42°C for 20 min for bacteriophage induction. At this stage, isopropyl-P-D-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM to induce the lacZ promoter of Xgtll. Lysogens were further incubated with heavy aeration for an additional 3 to 5 h at 37°C. Cells were recovered by centrifugation at 5,000 x g for 10 min and lysed by repeated freeze-thawing in liquid nitrogen. DNase I (Sigma) was then added to a final concentration of 20 ,ug/ml, and the lysates were incubated at room temperature for 15 min. Cell debris was separated by centrifugation at 10,000 x g for 20 min, and supernatants were saved for further analysis. Antisera. Antiserum against E. rhusiopathiae was obtained from a 4-month-old pig 8 weeks after recovery from an experimental infection with an intravenous inoculation of 3 x 109 CFU of strain E1-6P. To prepare antisera against recombinant proteins, guinea pigs were inoculated subcutaneously with lysates (500 ,ug of protein) from E. coli Y1089(XgtllIersA) and Y1089(XgtllIersB) homogenized with equal amounts of complete Freund adjuvant. Antiserum to Y1089(Agtll) was prepared by a similar procedure. To remove cross-reacting antibodies, all antisera were extensively absorbed with a lysate of E. coli Y1089(Agtll) adsorbed onto nitrocellulose filters (Schleicher & Schuell, Inc., Keene, N.H.) before being used in the different assays.
DNA manipulations. Large quantities of Xgtll bacteriophage DNA were obtained from E. coli Y1088 by procedures described by Maniatis et al. (15) . Recombinant phage DNA was obtained by the method of Ivanov and Gigova (10) . Plasmid DNA was isolated as described previously (2) . Total cell DNA from E. rhusiopathiae strains was obtained as follows. Cells were grown overnight in brain heart infusion broth supplemented with 10% horse serum, recovered by centrifugation at 9,000 x g, and washed twice with TE buffer (10 mM Tris [pH 7.6], 1 mM EDTA). Cells were resuspended in 2 ml of TE buffer containing lysozyme (20 mg/ml; Sigma) and N-acetylmuramidase SG (50 ,xg/ml; Seikagaku Kogyo Co., Tokyo, Japan) and placed in a 10-ml ultracentrifuge tube. After 1 h of incubation at 37°C, 1 ml of TE buffer containing 10 mg of preincubated pronase (CalbiochemBehring, La Jolla, Calif.) was added, and the mixture was incubated at 37°C for 30 min. Cells were lysed with 1 ml of 20% sodium dodecyl sulfate (SDS) solution, and the tubes were filled with TE buffer containing CsCl to give a final concentration of 1 g/ml and 0.8 ml of a 10-mg/ml solution of ethidium bromide. DNA was recovered after centrifugation to equilibrium in a CsCl gradient. Packaging mixes of bacteriophage X were prepared from strains BHB2688 and BHB2690 as described by Hohn (9) . Restriction endonucleases were purchased from Bethesda Research Laboratories, Inc. (Gaithersburg, Md.) or Boehringer Mannheim Biochemicals (Indianapolis, Ind.) and were used as recommended by the manufacturers. Transfer of DNA to nylon membranes (GeneScreenPlus; Dupont, NEN Research Products, Boston, Mass.) was carried out according to the method of Southern (21) . Hybridization were performed with [32P]dCTP-labeled probes according to standard procedures (15) .
Construction and screening of bacteriophage libraries. E. rhusiopathiae E1-6P total cell DNA was partially digested with EcoRI, and fragments ranging from 1 to 8 kilobase pairs (kb) were isolated on a sucrose gradient. Agtll DNA was ligated overnight with T4 DNA ligase (Boehringer Mannheim), digested with EcoRI, and treated with alkaline phosphatase (Boehringer Mannheim) before being ligated to the EcoRI fragments of E. rhusiopathiae DNA. The ligated DNA molecules were packaged into X phage particles as described previously (9) . Recombinant phage were plated on E. coli Y1089 to give approximately 300 plaques per plate. After incubation of the plates at 42°C for 4 to 6 h, nitrocellulose filters (82 mm; Schleicher & Schuell) previously impregnated with 10 mM IPTG were overlaid, and the plates were incubated at 37°C for an additional 8 to 12 h. rhusiopathiae E1-6P convalescent pig serum for 2 h. Filters were then washed in NET buffer for 30 min, incubated with peroxidase-labeled goat anti-pig antiserum for 2 h, and finally developed with 4-chloro-1-naphthol. Plaques giving a positive signal were picked, suspended in SM medium (15) , saturated with chloroform, and rescreened until all plaques on the filter gave a positive signal. Recombinant phages were then lysogenized into E. coli Y1089 as described previously (34) . Recombinant clones were further screened for ability to induce protection in immunized mice. Groups of four 8-week-old inbred female mice of the ICR strain were used for each clone, and two doses of 500 p.g of protein from lysates adsorbed to aluminum hydroxide (Alhydrogel) were given subcutaneously 15 days apart. Mice were then challenged subcutaneously with 100 50% lethal doses of E. rhusiopathiae E1-6P 2 weeks after the booster dose, and deaths were scored for up to 15 days after challenge. Clones showing protective abilities were further tested by immunizing a larger number of mice as described above. Fig. 1 . The recombinant clones appeared as high-molecular-weight polypeptides when reacted with pig antiserum against E. rhusiopathiae. Coomassie blue-stained SDS-polyacrylamide gels of the same preparations showed the absence of polypeptides at the expected size of the P-galactosidase and instead showed the presence of higher-molecular-weight polypeptides of similar size than those observed in Western immunoblots (data not shown). These findings, in conjunction with the fact that these polypeptides were observed only in IPTGinduced lysogens, strongly suggested that the cloned determinants in XgtllIersA and XgtlllersB were fused to the ,B-galactosidase gene of the Xgtll vector.
Reactivities of antisera against Agtll/ersA and gtlllersB. Figure 2 shows the reactivities of antisera against XgtllIersA and gtlllersB when reacted with detergent-solubilized surface antigens and whole-cell extracts of E. rhusiopathiae E1-6P. Antiserum against XgtllIersA recognized polypeptides with molecular weights of 66,000, 64,000, and 43,000 in both antigen preparations (Fig. 2a) against AgtllIersB reacted strongly with polypeptides of molecular weights 64,000 and 43,000 and weakly with the 66,000-molecular-weight polypeptide in the same preparation (Fig. 2b) . In Fig. 2c , the reactivities of the E. rhusiopathiae convalescent pig serum used for screening of the libraries are shown. This antiserum recognized several immunologically reactive polypeptides in both antigenic preparations, the most prominent being the same polypeptide bands recognized by the recombinant antisera with molecular weights of 66,000, 64,000, and 43,000. A silver stain of the same antigenic preparations is shown in Fig. 2d . The polypeptide of molecular weight 64,000 to 66,000 appeared as one of the most abundant polypeptide species in the detergentsolubilized surface antigen preparation. An abundant lowermolecular-weight band was also present in the Triton X-100 extract. Lachmann and Deicher (12) have identified this lower-molecular-weight band as a polysaccharide. Guinea pig antiserum against Y1089(Agtll) showed no reactivities when tested against the same antigenic preparations (data not shown).
Characterization of the insert DNA fragment of Agtll/ersA and Xgtll/ersB. Agarose gel electrophoresis of EcoRI digests of XgtllIersA and XgtllIersB DNA revealed the presence of a 5.4-kb insert (Fig. 3) . Insert DNA from XgtlllersA was subcloned into the plasmid vector pUC8-2 (8), yielding plasmid pSBOOl. A restriction endonuclease site map of the insert DNA is shown in Fig. 4 . No difference between the restriction maps of the inserts of XgtllIersA and AgtllIersB was observed. In addition, pSBOOl insert DNA hybridized to AgtllIersB insert DNA (Fig. 3) , strongly suggesting that the two clones are identical.
Presence of the cloned antigenic determinants in different strains of E. rhusiopathiae. The presence of the cloned antigenic determinants of Xgtll/ersA and Xgtll/ersB in detergent-solubilized proteins of different strains of E. rhu- siopathiae was determined by Western blot analysis, using the antisera against XgtllIersA and XgtllIersB. Antiserum against XgtllIersA reacted to varying degrees with the 66,000-and 43,000-molecular-weight polypeptides in all strains tested (Fig. 5) . Similar results were obtained with XgtlllersB antiserum (data not shown). In addition, Southern hybridization analysis with the XgtlllersA insert DNA fragment revealed the presence of DNA sequences sharing homology in all strains tested. The cloned DNA fragment hybridized with an EcoRI fragment of 5.4 kb in all strains except strains 2179, S-192, and NF-4, in which it hybridized with different-size fragments (Fig. 3) .
DISCUSSION
We have cloned and expressed in E. coli a protective protein antigen of E. rhusiopathiae. Lysates of XgtllIersA and XgtllIersB protected mice against subcutaneous challenge with 100 50% lethal doses of virulent E. rhusiopathiae E1-6P. Mice immunized with the recombinant protein showed statistically significant longer times to death and higher percentage of survivors than did controls (Table 2) . Nevertheless, protection was not complete, since less than 20% of the immunized mice ultimately survived the challenge. Several factors may account for these findings. It is possible that ,-galactosidase is immunodominant and inter- feres with the response to the E. rhusiopathiae protein. A similar finding has been reported for the VP1 protein of foot-and-mouth disease virus, which induced a less effective immune response when fused to P-galactosidase (30 43 ,000 in whole-cell extracts and Triton X-100-solubilized surface proteins of E. rhusiopathiae (Fig. 2a) . Antisera to AgtlllersA and AgtllIersB showed slightly different reactivities (Fig. 2b) . Nevertheless, we have been unable to detect differences between these two clones by using Southern hybridization and restriction analysis. Most likely, the guinea pigs immunized with each lysate may have responded differently to the immunogen, not an unexpected finding considering the outbred nature of these animals.
The three proteins in the extracts of E. rhusiopathiae recognized by the recombinant protein antisera appeared among the most reactive proteins when the immunoblots were developed with convalescent pig antiserum (Fig. 2c) . In addition, convalescent pig antiserum strongly reacted with a 70,000-molecular-weight protein in both whole-cell extracts and Triton X-100 preparations. Lachmann and Deicher described several immunologically reactive proteins in similar preparations of E. rhusiopathiae, using a rabbit antiserum against heat-killed E. rhusiopathiae (12) . The 66,000-and 43,000-molecular-weight proteins were the most prominent antigens reacting with the rabbit antiserum. In the same work, these authors established the surface location of these proteins. As shown in the silver stain of Fig. 2d , the 66,000-molecular-weight protein appears as the most abundant detergent-solubilized surface protein of E. rhusiopathiae. Although insufficient information is available regarding the relationship between the 66,000-, 64,000-, and 43,000-molecular-weight proteins, it is possible that the lower-molecular-weight proteins are processed or degraded forms of the larger molecule. Lachman and Deicher found that rabbits immunized with heat-killed E. rhusiopathiae made antibodies to a low-molecular-weight polysaccharide that is abundant in Triton X-100 preparations of this organism (12) . Our immunoblots showed no reactivity of convalescent pig antiserum to such a polysaccharide although it was present in large amounts in the preparations used in the analysis shown in Fig. 2d .
Peptidoglycan antigens form the basis of the classification of E. rhusiopathiae into at least 22 serotypes. The degree of relatedness of the protein antigens among the different serotypes is not known, although varying degrees of crossprotection have been observed (23) . We determined the distribution of the cloned protein among different serotypes of E. rhusiopathiae of veterinary importance by using the antisera against the cloned determinants. Figure 5 shows a Western blot of detergent-solubilized proteins of different strains of E. rhusiopathiae developed with the XgtlllersA antiserum. The 66,000-and 43,000-molecular-weight polypeptides were present in varying amounts in all strains tested. Strains of low or moderate virulence showed less reactivity than virulent strains, although the significance of these findings is still unclear. There was no correlation between serotype and amount of reactivity. Southern hybridization analysis revealed DNA sequences sharing homology with the cloned fragments in all strains tested regardless of virulence or serotype, although some restriction fragment length polymorphism was apparent among the different strains (Fig. 3) .
A lack of correlation of serum antibody titers with protection against E. rhusiopathiae has been reported (24) . This finding may reflect the inadequacy of the antigen used in the tests (either whole cells for the agglutination test or crude cell extracts for the enzyme-linked immunosorbent assay). The availability of a protective antigen free of other nonrelevant antigens will help in the development of improved in vitro methods for assessing immune status.
Although we have cloned and expressed in E. coli a protein of E. rhusiopathiae that stimulates partial protection of mice against challenge with a highly virulent strain of this organism, immunization studies are needed to evaluate the protective ability of this recombinant protein in the pig. None of the immunized mice that survived the challenge with the virulent strain of E. rhusiopathiae developed arthritic lesions; nevertheless, additional experiments in pigs will be necessary to determine whether the cloned determinant can sensitize these animals to subsequent contact with the organism and therefore predispose them to development of arthritic lesions. The results of such studies will establish the feasibility of using protective epitopes on this protein in a subunit vaccine against erysipelas.
